Subscribe
Models
Our Products
Featured Catalog
Humanized Mouse Models
Tool Mice
Custom Model Services
Preclinical Solutions
Resources
About Us
hSTAT2 Mouse
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
hSTAT2 Mouse
Product Name
hSTAT2 Mouse
Product ID
C002141
Strain Name
C57BL/6Cya-Stat2em1(hSTAT2)/Cya
Background
C57BL/6Cya
Status
When using this mouse strain in a publication, please cite “hSTAT2 Mouse (Catalog C002141) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
Standard products are sold as live mice derived from cryorecovery or expansion. Frozen materials are available upon request. Pricing and lead times depend on real-time inventory.
Basic Information
Related Resource
Basic Information
Gene Name
STAT2
Gene Alias
P113, IMD44, ISGF-3, PTORCH3, STAT113
NCBI ID
Chromosome
Chr 12 (Human)
MGI ID
Datasheet
Strain Description
The Stat2 (signal transducer and activator of transcription 2) gene encodes signal transducer and activator of transcription 2 (STAT2), a key transcriptional regulator in interferon-mediated innate immune responses. In the classical signaling pathway, type I or type III interferons bind to their cognate receptors and activate the JAK-STAT signaling pathway, promoting phosphorylation of STAT1 and STAT2. Subsequently, STAT1, STAT2, and interferon regulatory factor 9 (IRF9) form the interferon-stimulated gene factor 3 (ISGF3) complex, which translocates to the nucleus and regulates the expression of interferon-stimulated genes (ISGs), thereby mediating antiviral immune responses. In addition, STAT2 can also participate in interferon-mediated gene expression and immune regulation through STAT1-independent transcriptional complexes [1].
In recent years, research on STAT2 has expanded from classical antiviral signal transduction to directions such as viral immune evasion, the tumor microenvironment, and immune regulation mediated by chronic interferon signaling. In virus infection research, some viruses can suppress host interferon responses by targeting STAT2. For example, dengue virus (DENV) nonstructural protein NS5 specifically binds and promotes degradation of human STAT2, but has limited effect on mouse STAT2, indicating that species differences in STAT2 are an important factor affecting viral host range and immune evasion [2]. In addition, studies have found that human metapneumovirus (HMPV) can promote viral infection by inhibiting STAT2-related interferon signaling, and virus-infection-related phenotypes and suppression of type I interferon signaling were observed in hSTAT2 knock-in mice [3]. In tumor research, STAT2-mediated interferon signaling has dual regulatory roles: early interferon responses can promote antigen presentation and CD8+ T cell-mediated antitumor immunity, whereas sustained interferon signaling and noncanonical STAT2-associated transcriptional complexes may be involved in immunosuppression, tumor cell survival, and chemoresistance in specific tumor contexts [4].
The hSTAT2 mouse is constructed by replacing the start codon of the mouse Stat2 gene with the "Human STAT2 CDS-rBG pA" cassette. This model can be used for in vivo efficacy and safety evaluation of drug candidates that need to recognize human STAT2, and is also applicable to research in fields such as viral immune evasion and antiviral drug development, tumor immunity and inflammation-related diseases, interferon signaling pathways, and immune regulation.
Reference
Fink K, Grandvaux N. STAT2 and IRF9: Beyond ISGF3. JAK-STAT. 2013;2(4):e27521.
Ashour J, Morrison J, Laurent-Rolle M, et al. Mouse STAT2 restricts early dengue virus replication. Cell Host & Microbe. 2010;8(5):410–421.
Rogers MC, Miranda-Katz M, Zhang Y, et al. STAT2 Limits Host Species Specificity of Human Metapneumovirus. Viruses. 2020;12(7):724.
Canar J, Darling K, Dadey R, Gamero AM. The duality of STAT2 mediated type I interferon signaling in the tumor microenvironment and chemoresistance. Cytokine. 2023;161:156081.
Strain Strategy
The start codon of the mouse Stat2 gene was replaced with "Human STAT2 CDS-rBG pA" cassette.

Figure 1. Gene editing strategy of hSTAT2 mice.
Application Area
Screening, pharmacodynamic evaluation, safety evaluation, and mechanism of action studies on drugs targeting the STAT2 target;
Research on viral immune evasion mechanisms and antiviral drugs;
Research on tumor immunity and inflammation-related diseases;
Research on interferon signaling pathways, immune regulation, and related areas.
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
